Filing Details

Accession Number:
0001628280-23-006541
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-06 16:37:04
Reporting Period:
2023-03-02
Accepted Time:
2023-03-06 16:37:04
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1551306 Progyny Inc. PGNY Services-Misc Health & Allied Services, Nec (8090) 272220139
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1576147 Peter Anevski C/O Progyny, Inc.
1359 Broadway, 2Nd Floor
New York NY 10018
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-02 32,000 $3.95 255,901 No 4 M Direct
Common Stock Disposition 2023-03-02 25,758 $35.97 230,143 No 4 S Direct
Common Stock Disposition 2023-03-02 5,988 $36.67 224,155 No 4 S Direct
Common Stock Disposition 2023-03-02 254 $37.79 223,901 No 4 S Direct
Common Stock Disposition 2023-03-02 6,440 $35.97 109,398 No 4 S Indirect See footnote
Common Stock Disposition 2023-03-02 1,496 $36.67 107,902 No 4 S Indirect See footnote
Common Stock Disposition 2023-03-02 64 $37.79 107,838 No 4 S Indirect See footnote
Common Stock Acquisiton 2023-03-03 32,000 $3.95 255,901 No 4 M Direct
Common Stock Disposition 2023-03-03 32,000 $36.25 223,901 No 4 S Direct
Common Stock Disposition 2023-03-03 8,000 $36.26 99,838 No 4 S Indirect See footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 M Direct
No 4 S Direct
No 4 S Indirect See footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2023-03-02 32,000 $0.00 32,000 $3.95
Common Stock Stock Option (Right to Buy) Disposition 2023-03-03 32,000 $0.00 32,000 $3.95
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
1,160,515 2029-05-23 No 4 M Direct
1,128,515 2029-05-23 No 4 M Direct
Footnotes
  1. Shares sold pursuant to a Rule 10b5-1 trading plan entered into on July 5, 2022.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.49 to $36.49, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.50 to $37.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.72 to 37.90, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  5. The reportable securities are held directly by the PECO ANEVSKI 2020 SD LLC.
  6. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.79 to $36.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  7. One-fourth (1/4th) of the shares subject to the Option vested on May 23, 2020, and one thirty-sixth (1/36th) of the remaining shares subject to the Option vested or shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.